Results 11 to 20 of about 22,264 (222)
THROMBOTIC THROMBOCYTOPENIC PURPURA
Eurasian Journal of Medicine, 2019 Thrombotic thrombocytopenic purpura is characterized by microangiopathic hemolytic anemia, thrombocytopenia, fever, neurologic abnormalities and renal dysfunction.The typical pathologic lesion, widespread hyalin oclusions in arterioller.
Ali Rıza Odabaş +2 more
doaj +5 more sources
Vitamin B12 Deficiency-Associated Pseudo-Thrombotic Microangiopathy in a Patient on Longstanding Oral B12 Supplementation. [PDF]
Clin Case RepABSTRACT Vitamin B12 deficiency is a common cause of normocytic or megaloblastic anemia. In 2.5% of cases, it can manifest as pseudo‐thrombotic microangiopathy (pseudo‐TMA), which mimics thrombotic thrombocytopenic purpura (TTP), an emergent hemolytic microangiopathy.
Bertucci HK, Moy BM, Stein R.
europepmc +2 more sources
Thrombotic thrombocytopenic purpura [PDF]
Blood, 2017 AbstractThrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and organ ischemia linked to disseminated microvascular platelet rich-thrombi.
Bérangère S, Joly +2 more
openaire +6 more sources
Thrombotic Thrombocytopenic Purpura
Apollo Medicine, 2005 This overview summarizes the history of thrombotic thrombocytopenic purpura (TTP) from its initial recognition in 1924 as a most often fatal disease to the discovery in 1997 of ADAMTS-13 deficiency as a major risk factor for acute disease manifestation.
Salil Jain +3 more
doaj +4 more sources
How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome [PDF]
, 2014 Thrombotic thrombocytopenic purpura (TTP) and atypical haemolytic uraemic syndrome (aHUS) are acute, rare life-threatening thrombotic microangiopathies that require rapid diagnosis and treatment.
Goodship, T, Scully, M
core +1 more source
Thrombotic thrombocytopenic purpura [PDF]
The Journal of the American Osteopathic Association, 1989 Once formerly thought to be a rare disorder, thrombotic thrombocytopenic purpura (TTP) is becoming increasingly recognized. It is characterized by a pentad of clinical findings, including microangiopathic hemolytic anemia, thrombocytopenic purpura, neurologic and renal abnormalities, and fever.
openaire +2 more sources
Thrombotic thrombocytopenic purpura [PDF]
memo - Magazine of European Medical Oncology, 2018 Thrombotic thrombocytopenic purpura (TTP) is a clearly defined entity of the thrombotic microangiopathies (TMA), a heterogeneous group of disorders characterized by microangiopathic hemolytic anemia with red cell fragmentation, thrombocytopenia and organ dysfunction due to disturbed microcirculation.
openaire +2 more sources
Characterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias: a single institution experience. [PDF]
, 2014 Plasma exchange (PEX) is a life-saving therapeutic procedure in patients with thrombotic thrombocytopaenic purpura (TTP) and other thrombotic microangiopathic anaemias (TMAs). However, it may be associated with significant complications, exacerbating the
Collier, D +5 more
core +2 more sources
Hereditary thrombotic thrombocytopenic purpura
Haematologica, 2019 The first description of thrombotic thrombocytopenic purpura (TTP) by Moschowitz was published nearly 100 years ago.[1][1] This was likely to have been an immune-mediated TTP episode and the author described multi organs affected with worsening, untreated disease.
Marie Scully
doaj +7 more sources
Balkan Medical Journal, 2018 Background: Thrombotic thrombocytopenic purpura is a potentially life-threatening condition. Although the introduction of therapeutic plasma exchange has reduced mortality rates from over 90% to 10%-20%, approximately 40% of patients relapse, and ...
Seniz Öngören +9 more
doaj +1 more source